Multiple Sclerosis News Today

June 21, 2021June 21, 2021

Oral Aubagio Approved in EU for Children With RRMS, Ages 10-17

The European Commission (EC) has approved Aubagio (teriflunomide) for the treatment of children and adolescents, ages 10 to 17, with relapsing-remitting multiple sclerosis (RRMS). Aubagio, approved for adults with RRMS since ... Read more

June 21, 2021June 21, 2021

Results: Ponvory Outperforms Aubagio in OPTIMUM Clinical Trial

Multiple Sclerosis News Today

In the OPTIMUM clinical trial, Ponvory (ponesimod) significantly outperformed Aubagio (teriflunomide) in reducing relapse rates, fatigue, and evidence of brain damage among people with relapsing multiple sclerosis (MS). Based on these ... Read more

June 18, 2021June 18, 2021

Brainstorm Secures NurOwn-associated Patents in Several Markets

Multiple Sclerosis News Today

In the past year, BrainStorm Cell Therapeutics was granted four patents and is waiting for a fifth, already accepted, meant to provide protection for its NurOwn cell therapy and technology ... Read more

June 18, 2021June 18, 2021

Younger Age, DMT Use at Early Relapse May Lessen Later Disability

Multiple Sclerosis News Today

People with multiple sclerosis (MS) who are using a disease-modifying therapy — and are at a younger age — when they have a relapse within the first three years of their disease ... Read more

June 17, 2021June 17, 2021

$1M Gift Will Expand Adventure-based Healing Program

COVID-19 News, Multiple Sclerosis News Today

A $1 million gift from Velocity Global will help expand First Descents, an adventure program for young adults living with multiple sclerosis (MS) or other serious chronic conditions. The money ... Read more

June 17, 2021June 17, 2021

MS Does Not Raise Woman’s Risk of Child With Brain Disorder, Study Suggests

Multiple Sclerosis News Today

Children born to women with multiple sclerosis (MS) are not at a higher risk of brain disorders than are children whose mothers don’t have this disease, an observational study reported. ... Read more

June 16, 2021June 17, 2021

Data on T-cell Repertoire May Help in Understanding MS Development

Multiple Sclerosis News Today

T-cells in the fluid around the brain share a large percentage of receptors among different multiple sclerosis (MS) patients, a new report suggests. Better understanding the diversity of T-cell receptors ... Read more

June 16, 2021June 16, 2021

Stopping Cannabis Aids Cognition in MS, But Not Awareness of Gains

Multiple Sclerosis News Today

People with multiple sclerosis (MS) may not be entirely aware of the decline in their cognitive abilities with cannabis use, which may explain why many choose to continue with it, ... Read more

June 15, 2021June 15, 2021

Home-based Exercise Viable Alternative for RRMS Patients

Multiple Sclerosis News Today

A home-based rehabilitation program can help ease fatigue, improve motor and cognitive function, and promote better quality of life in people with relapsing-remitting multiple sclerosis (RRMS), a small clinical trial ... Read more

June 15, 2021June 15, 2021

FDA Rejects Expansion of Aubagio for Pediatric MS

Multiple Sclerosis News Today

The U.S. Food and Drug Administration (FDA) has rejected an application requesting the expansion of Aubagio (teriflunomide) for the treatment of children and adolescents, ages 10 to 17, with relapsing ... Read more

June 14, 2021June 14, 2021

Shepherd Center, BurnAlong Open Global Online Rehab Classes for MS

Multiple Sclerosis News Today

BurnAlong and the Shepherd Center, a leading rehabilitation hospital in the U.S., have established a partnership to bring tailored rehabilitation classes to people with multiple sclerosis (MS) and other neuromuscular diseases worldwide. ... Read more

June 14, 2021June 14, 2021

Scientists Discover Enzyme Needed for Activating Myelin Repair

Multiple Sclerosis News Today

The enzyme TET1, which is progressively lost with age, is essential to activate genes needed to repair myelin — the sheath around nerve cells that is damaged in people with ... Read more

June 11, 2021June 11, 2021

Stem Cell Transplant Trial Enrolls First Patient in Minnesota

Multiple Sclerosis News Today

A clinical trial investigating patient-derived stem cell transplants for the treatment of people with severe relapsing forms of multiple sclerosis (MS) has enrolled a patient in Minnesota. The patient was ... Read more

June 11, 2021June 11, 2021

University Alumni Donate $7.5M to Support Research Into MS, Like Diseases

Multiple Sclerosis News Today

John and Catherine Seibyl, both alumni of Case Western Reserve University (CWRU) in Ohio, have pledged $7.5 million to the university to advance multidisciplinary research into multiple sclerosis (MS) and ... Read more

June 10, 2021June 10, 2021

Gilenya’s Optimal Dose for RRMS Confirmed in Review of Clinical Trials

Multiple Sclerosis News Today

Gilenya (fingolimod) at its approved 0.5 mg daily dose continues to be the optimal dose for people with relapsing-remitting MS (RRMS), a systematic review of 11 clinical trials confirmed. A 0.25 mg/day ... Read more